The coronary artery bypass graft market has seen considerable growth due to a variety of factors.
•Over the past several years, the coronary artery bypass graft market has seen substantial growth. Its size is projected to increase from $12.58 billion in 2024 to $13.66 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%.
The market's expansion during the historical period is due to factors such as an aging population, the improvement of healthcare infrastructure, a surge in cardiovascular diseases, awareness movements, and insurance coverage.
The coronary artery bypass graft market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to witness robust expansion in the upcoming years, the market size of coronary artery bypass graft is projected to reach $19.32 billion in 2029, escalating at a compound annual growth rate (CAGR) of 9.1%.
The predicted growth during this forecast period stems from the growth of ambulatory surgery centers (ASCS), integration of digital health measures, expansion of telemedicine, usage of remote patient monitoring devices, and the adoption of patient-centric approaches. Key trends to watch out for in this forecast period involve progress in surgical methodologies, cooperative research, application of robotics in surgery, usage of biodegradable implants, leveraging AI for diagnosis, and the adoption of virtual reality for surgical training.
The rising incidence of cardiovascular diseases is anticipated to fuel the expansion of the coronary artery bypass graft market in the future. Cardiovascular disease (CVD) widely includes various disorders of the heart and blood vessels. A coronary artery bypass graft (CABG) procedure is advised to diminish the likelihood of a heart attack by constructing a new pathway for the blood to circulate around obstructed or semi-obstructed arteries in the heart. For example, a journal published by Oxford University Press, a UK-based university press of the University of Oxford, noted in March 2023 that there would be a 50% increase in the population affected by peripheral artery diseases by 2045. Hence, the escalating incidence of cardiovascular diseases is propelling the growth of the coronary artery bypass graft market.
The coronary artery bypass graft market covered in this report is segmented –
1) By Procedure: Single Coronary Artery Bypass Graft (CABG) Surgery, Double Coronary Artery Bypass Graft (CABG) Surgery, Triple Coronary Artery Bypass Graft (CABG) Surgery, Quadruple Coronary Artery Bypass Graft (CABG) Surgery, Other Procedures
2) By Method: Off-pump, On-pump
3) By End-Use: Hospitals, Cardiology Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Single Coronary Artery Bypass Graft (CABG) Surgery: Left Internal Mammary Artery (LIMA) To Left Anterior Descending Artery (LAD), Other Single Graft Procedures
2) By Double Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD and Another Artery, Other Combinations Of Two Arteries
3) By Triple Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD And Two Other Arteries, Other Combinations Of Three Arteries
4) By Quadruple Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD And Three Other Arteries, Other Combinations Of Four Arteries
5) By Other Procedures: Off-Pump CABG, Minimally Invasive CABG, Hybrid Procedures
The coronary artery bypass graft market is seeing an increasing trend of strategic partnerships. This is a common approach employed by key companies in the market to solidify their standings and obtain a competitive edge. A case in point is Medtronic PLC, a medical device company based in the US which, in July 2022, entered into a partnership with CathWorks, a medical equipment manufacturer from Israel. As part of this deal, Medtronic plans to invest up to $75 million in CathWorks and jointly market CathWorks' FFRangio System not only in the US, but also in Japan and Europe.
Major companies operating in the coronary artery bypass graft market include:
• CryoLife Inc.
• Johnson & Johnson Co
• Abbott Laboratories
• Medtronic plc
• Stryker Corporation
• Northwell Health
• Boston Scientific Corporation
• Penn Medicine
• Geisinger Health System Co
• Terumo Corporation
• Edwards Lifesciences Corporation
• Main Line Health Inc.
• Getinge AB
• Teleflex Incorporated
• W. L. Gore & Associates Inc.
• Guidant Group
• LivaNova PLC
• AtriCure Inc.
• Peter Surgical
• Cardiva Medical Inc.
• Genesee Biomedical Inc.
• Dextera Surgical Inc.
• Cardica Inc.
• Maquet Holding B.V. & Co.KG
• Vitalitec International Medizintechnik GmbH
• Hancock Jaffe Laboratories.
North America was the largest region in the coronary artery bypass graft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary artery bypass graft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa